Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 07, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 51,531 | $8.61 | 214,735 | |
| Aug 05, 2022 | Chief People Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 11,322 | $12.50 | 215,542 | |
| Oct 02, 2020 | Chief Financial Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 11,000 | $2.45 | 218,179 | |
| Aug 20, 2014 | Chief Operating Officer | Open market or private purchase of non-derivative or derivative security | Form 4 | 18,750 | $5.40 | 218,750 | |
| Jan 06, 2023 | Chief People Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 21,507 | $11.87 | 219,566 | |
| Jan 15, 2021 | Chief Legal Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 8,794 | $21.84 | 220,705 | |
| Jul 27, 2007 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 14,100 | $11.40 | 220,979 | |
| Jul 27, 2007 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 14,100 | $11.40 | 220,979 | |
| Jul 27, 2007 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 100 | $11.42 | 221,079 | |
| Jul 27, 2007 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 100 | $11.42 | 221,079 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.